Showing results (321-330 of 483) with videos related to
Sort By:
Pageof 49
Journal of Hepatology|July 25, 2000
The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertensionC Chagneau, K A Tazi, J Heller, et al.Journal of Gastroenterology and Hepatology|February 24, 2001
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donorP Lefilliatre, P Sogni, V Bertrand, et al.Journal of Hepatology|April 1, 1994
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonistsP Sogni, T Soupison, R Moreau, et al.Hepatology (Baltimore, Md.)|October 26, 2000
Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosisE Barriere, K A Tazi, J P Rona, et al.Journal of Gastroenterology and Hepatology|January 26, 1999
In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosisR Moreau, F Oberti, P Lahaye, et al.European Journal of Pharmacology|May 7, 1998
Acute and chronic haemodynamic effects of naftazone in portal hypertensive ratsP Sogni, S Yang, C Pilette, et al.Journal of Hepatology|November 21, 1998
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeA Hadengue, A Gadano, R Moreau, et al.Hepatology (Baltimore, Md.)|October 1, 1992
Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosisP Sogni, R Moreau, M Ohsuga, et al.Hepatology (Baltimore, Md.)|September 10, 1998
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive ratsP Sogni, R Moreau, A Gomola, et al.The Journal of Infectious Diseases|April 1, 1992
Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-VirauxN Boyer, P Marcellin, C Degott, et al.Pageof 49